Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999
A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998
Long-Term Postoperative Cognitive Dysfunction in the Elderly:ISPOCD1 Study
Lancet 351:857-861, Moller,J.T.,et al, 1998
Herpes Simplex Encephalitis Treated with Acyclovir:Diagnosis and Long Term Outcome
JNNP 63:321-326, McGrath,N.,et al, 1997
Extent of Pontine Pyramidal Tract Wallerian Degeneration and Outcome after Supratentorial Hemorrhagic Stroke
Stroke 25:1207-1210, Fukui,K.,et al, 1994
Clinicopath Conf
Pick's Diseae, Case 6-1992, NEJM 326:397-405992., , 1992
Evaluation of Long-Term Outcome and Safety After Hemodilution Therapy in Acute Ischemic Stroke
Stroke 23:657-662, Strand,T., 1992
Level of Function Predicts First Stroke in the Elderly
Stroke 23:1355-1357, Colantonio,A.,et al, 1992
A Critical Appraisal of Stroke Evaluation and RAting Scales
Stroke 22:1345-1352, Lyden,P.D.&Lau,G.T., 1991
Effect of Demebon on Cognition, Activities of Daily Living, Behavior, and Global Function in Patients With Mild-To-Moderate Alzheimers Disease: A Randomised, Double-Blind, Placebo-Controlled Study
Lancet 372:207-215,179, Doody, R.S.,et al., 2008
Health Outcomes 1 Year After Subarachonid Hemorrhage
Neurol 55:658-662, Hackett,M.L. et al, 2000
Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999
Recovery Following Lateral Medullary Infarction
Neurol 50:1418-1422, Nelles,G.,et al, 1998
Electrical Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
NEJM 339:1105-1111, Limousin,P.,et al, 1998
A Prediction Model for Functional Recovery in Stroke
Stroke 28:550-556, Stineman,M.G.,et al, 1997
Impact of Thalamic Hematoma on Six-Month Mortality and Motor and Cognitive Functional Outcome
Stroke 26:620-626, Mori,S.,et al, 1995
Influence of Age on Stroke Outcome:Copenhagen Stroke Study
Stroke 25:808-813, Nakayama,H.,et al, 1994
Prevention of Functional Impairment by Endarterectomy for Symptomatic High-Grade Carotid Stenosis
JAMA 271:1256-1259, Haynes,R.B.,et al, 1994
The Effects of Long-Term Rehabilitation Therapy on Poststroke Hemiplegic Patients
Stroke 24:1186-1191, Dam,M.,et al, 1993
The Frenchay Activities Index, Assessment of Functional Status in Stroke Patients
Stroke 24:1173-1177, Schuling,J.,et al, 1993
Major Depression in Stroke Patients:A 3-Year Longitudinal Study
Stroke 24:976-982, Astrom,M.,et al, 1993
Can Sensory Stimulation Improve the Functional Outcome in Stroke Patients?
Neurol 43:2189-2192, Johansson,K.,et al, 1993
Unilateral Transpl of Human Fetal Mesencephalic Tissue Into the Caudate Nucleus of Pts with Parkinson's
NEJM 327:1541-1548, Spencer,D.D.,et al, 1992
Survival of Implanted Fetal Dopamine Cells & Neuro Improvement 12 to 46 Months after Transpl for Parkinson's
NEJM 327:1549-1555, 15891992., Freed,C.R.,et al, 1992
Bilateral Fetal Mesencephalic Grafting in Two Patients with Parkinsonism Induced by MPTP
NEJM 327:1556-1563, 15891992., Widner,H.,et al, 1992
Interactive Effects of Age & Brain Disease on Reaction Time
Arch Neurol 34:369, Benton,A.L., 1977